Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

NCT06414460 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced/Metastatic Solid Tumors

Interventions

DRUG: ISM3412

Sponsor

InSilico Medicine Hong Kong Limited